Updated Jul 16, 2026 · Last SEC filing 2026-07-11
Janux Therapeutics, Inc. (JANX) has filed 10 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-11. 4 Form 8-K material event filings were reported by JANX in the last 90 days. 1 Form 144 notices of proposed sale were filed for JANX stock. InsiderAlpha tracks every JANX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001817713 |
|---|
| Form 4 filings (90d) | 10 |
|---|---|
| Form 8-K filings (90d) | 4 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-07-11 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Campbell David Alan | President and CEO | M — Option exercise | 7.0K | $4.21 | $29K | SEC | |
| Simson Jake | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| DOBMEIER ERIC | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| CAPPS VICKIE L | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| Hernday Natasha | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| RA CAPITAL MANAGEMENT, L.P. | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| Barrett Ronald W | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| Kung Winston | Insider | A — Grant or award | 5.5K | $0.00 | — | SEC | |
| Doyle Janeen Noel | Chief Corp. & Bus. Dev. Ofcr | S — Open-market sale | 4.1K | $14.03 | $57K | SEC | |
| Dobek Maria | Vice President, Accounting | S — Open-market sale | 2.0K | $14.17 | $29K | SEC | |
| Go William | Chief Medical Officer | A — Grant or award | 44.0K | $0.00 | — | SEC | |
| DOBMEIER ERIC | Insider | A — Grant or award | 3.8K | $0.00 | — | SEC | |
| CAPPS VICKIE L | Insider | A — Grant or award | 3.8K | $0.00 | — | SEC | |
| Campbell David Alan | President and CEO | S — Open-market sale [10b5-1] | 25.0K | $56.19 | $1.40M | SEC | |
| Meyer Andrew Hollman | Chief Business Officer | M — Option exercise | 1 | $14.02 | $14 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Janux Therapeutics, Inc. (JANX). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 2 | — |
| CAPPS VICKIE L | 2 | — |
| DOBMEIER ERIC | 2 | — |
| Campbell David Alan | 2 | $29K |
| Kung Winston | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in JANX insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live JANX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.